Kemper 5.875% Fixed Stock Earnings Reports

Kemper reported disappointing third-quarter 2025 results driven primarily by elevated bodily injury severity (notably in California after January 1 limit changes), increased attorney involvement / social inflation, and intensified competitive pricing in specialty auto. Reported GAAP net loss was $21 million (‑$0.34/sh), while adjusted consolidated net operating income was $20.4 million ($0.33/sh). The Specialty P&C underlying combined ratio widened (99.9% overall; personal auto 102.1%), with most adverse prior‑year development concentrated in commercial auto (accident years 2023 and prior). Management has launched a restructuring and made senior leadership changes (claims and IT) to improve execution and accountability; a $16.2 million after‑tax restructuring charge was recorded, with expected annual run‑rate savings of about $30 million. Kemper’s balance sheet and liquidity remain strong (over $1 billion available liquidity, 24.2% debt‑to‑capital), trailing 12‑month operating cash flow was $585 million, and $266 million of buybacks were completed between July and October (5.1M shares), with remaining buyback authorization available. Kemper Life performed well (operating earnings $19M) and continues to provide stable cash flow. Management will pursue targeted rate and non‑rate underwriting actions, claims management enhancements, and cost/efficiency initiatives while remaining disciplined on underwriting and selective on growth, especially in California, Florida, and Texas. Risks include ongoing severity trends, dynamic legal environment, competitive pricing pressure, and potential further adverse reserve development.